q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

April 2022 Medicare Drug List Updates: Seventy (70) medications added to the 2022 Medicare Part D Drug plan formularies.

Category: Monthly Formulary changes
Published: Apr, 19 2022 10:04:35
< Previous
Next >
The April 2022 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The April formulary updates include the addition of 70 new National Drug Codes (NDCs), representing 42 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the April 2022 Formulary updates include six (6) newly-added brand-name drugs

The April drug data updates include nineteen (19) new brand-name drugs, six (6) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • ADBRY®,
  • BYLVAY®,
  • CORTROPHIN®,
  • SKYTROFA®,
  • TARPEYO®, and
  • VOXZOGO®.

The April 2022 Formulary updates include five (5) newly-added generic drugs

The April Medicare Part D drug data also includes twenty-three (23) new generic medications, five (5) of which are newly-introduced generic drugs.  These new generic drugs include:
  • BRIMONIDINE-TIMOLOL [COMBIGAN®],
  • ESTRADIOL VALERATE [DELESTROGEN®],
  • LIDOCAINE [SOLUPAK®],
  • LIDOCAINE HCL [XYLOCAINE®], and
  • POTASSIUM CL [PROAMP®].

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of April 2022 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 70 new April 2022 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form2
New Drug18
New Drug and Strength31
New Drug, Delivery Form and Strength1
New Manufacturer and Delivery Form1
New Manufacturer and Strength9
New Manufacturer, Strength and Delivery Form3
New Strength5
Grand Total70

The following chart details the 70 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
72143023130ACCUTANE 10 MG CAPSULE [ZENATANE]52360New Strength
50222034604ADBRY 150 MG/ML SYRINGE116New Drug
57841120001AEMCOLO DR 194 MG TABLET DR017New Drug
78206011201ASMANEX HFA 100 MCG INHALER HFA AER AD26188New Drug and Strength
78206011301ASMANEX HFA 200 MCG INHALER HFA AER AD26188New Drug and Strength
78206011101ASMANEX HFA 50 MCG INHALER HFA AER AD26185New Drug and Strength
78206011501ASMANEX TWISTHALER 110 MCG #30 AER POW BA26187New Drug and Strength
78206011401ASMANEX TWISTHALER 220 MCG #120 AER POW BA26187New Drug and Strength
78206011404ASMANEX TWISTHALER 220 MCG #30 AER POW BA26187New Drug and Strength
78206011402ASMANEX TWISTHALER 220 MCG #60 AER POW BA26187New Drug and Strength
51672134004BETAMETHASONE DP AUG 0.05% LOTION [Diprolene]53379New Manufacturer and Delivery Form
61958250501BIKTARVY 30-120-15 MG TABLET63404New Strength
60505622500BRIMONIDINE-TIMOLOL 0.2%-0.5% DROPS [Combigan]8147New Drug
74528012001BYLVAY 1,200 MCG CAPSULE499New Drug and Strength
74528002001BYLVAY 200 MCG PELLET DSP CP499New Drug and Strength
74528004001BYLVAY 400 MCG CAPSULE499New Drug and Strength
78206011901CLARINEX 5 MG TABLET01New Drug
78206012001CLARINEX-D 12 HR 2.5-120 MG TABLET TBMP 12HR118New Drug
78670010001CORGARD 20 MG TABLET21New Manufacturer and Strength
78670010101CORGARD 40 MG TABLET21New Manufacturer and Strength
62559086015CORTROPHIN GEL 400 UNIT/5 ML VIAL171New Drug
00310758090CRESTOR 20 MG TABLET21New Strength
00310759030CRESTOR 40 MG TABLET21New Strength
00172640649CROMOLYN 20 MG/2 ML NEB SOLN AMPUL-NEB [Intal]63359New Drug
71800000301CYCLOBENZAPRINE 7.5 MG TABLET [Fexmid]279New Drug
68180094804DESOXIMETASONE 0.05% OINTMENT [Topicort LP]8109New Delivery Form
57664062388DEXMETHYLPHENIDATE ER 15 MG CPBP 50-50 [Focalin XR]7120New Manufacturer and Strength
57664062588DEXMETHYLPHENIDATE ER 30 MG CPBP 50-50 [Focalin XR]7120New Manufacturer and Strength
78206012402DIPROLENE 0.05% OINTMENT21New Drug
78206012701DULERA 100 MCG-5 MCG INHALER HFA AER AD20146New Drug and Strength
78206012601DULERA 200 MCG-5 MCG INHALER HFA AER AD20146New Drug and Strength
78206012501DULERA 50 MCG-5 MCG INHALER HFA AER AD20143New Drug and Strength
45802046653ECONAZOLE NITRATE 1% CREAM (G) [Spectazole]39299New Drug
63739005366ERYTHROMYCIN 2% GEL [Erygel]27249New Drug
00517044001ESTRADIOL VALERATE 200 MG/5 ML VIAL [Delestrogen]34297New Drug
00713022360FLUOCINOLONE 0.01% CREAM (G)51393New Drug
51862015860FLURANDRENOLIDE 0.05% OINTMENT [Cordran]015New Manufacturer and Strength
68180095102HYDROCORTISONE BUTYR 0.1% LOTION [Locoid]256New Delivery Form
67877047379LIDOCAINE 5% OINTMENT [SOLUPAK]42346New Manufacturer, Strength and Delivery Form
00054350547LIDOCAINE HCL 4% SOLUTION [Xylocaine]53368New Manufacturer, Strength and Delivery Form
51862061501MORPHINE SULFATE IR 15 MG TABLET [MSIR]63404New Manufacturer and Strength
51862061701MORPHINE SULFATE IR 30 MG TABLET [MSIR]63404New Manufacturer and Strength
00093216568NALOXONE HCL 4 MG NASAL SPRAY [Narcan]57369New Manufacturer, Strength and Delivery Form
64380083622NYSTATIN-TRIAMCINOLONE OINTMENT [Mytrex]39264New Drug
59212070012ORAPRED ODT 10 MG TABLET RAPDIS09New Drug and Strength
59212070112ORAPRED ODT 15 MG TABLET RAPDIS07New Drug and Strength
59212070212ORAPRED ODT 30 MG TABLET RAPDIS07New Drug and Strength
66992012814OTOVEL 0.3%-0.025% EAR DROPS VIAL12New Drug
63323096730POTASSIUM CL 60 MEQ/30 ML CONC VIAL [PROAMP]52380New Manufacturer and Strength
70954004110RIFABUTIN 150 MG CAPSULE [Mycobutin]63404New Drug
65862068730RITONAVIR 100 MG TABLET [Norvir]63404New Drug
78206017201SINGULAIR 10 MG TABLET21New Drug and Strength
78206017001SINGULAIR 4 MG CHEWABLE TABLET21New Drug and Strength
78206017101SINGULAIR 4 MG GRANULES GRAN PACK21New Drug, Delivery Form and Strength
78206017301SINGULAIR 5 MG CHEWABLE TABLET21New Drug and Strength
73362001001SKYTROFA 11 MG CARTRIDGE027New Drug and Strength
73362001101SKYTROFA 13.3 MG CARTRIDGE027New Drug and Strength
73362000301SKYTROFA 3 MG CARTRIDGE027New Drug and Strength
73362000401SKYTROFA 3.6 MG CARTRIDGE027New Drug and Strength
73362000501SKYTROFA 4.3 MG CARTRIDGE027New Drug and Strength
73362000601SKYTROFA 5.2 MG CARTRIDGE027New Drug and Strength
73362000701SKYTROFA 6.3 MG CARTRIDGE027New Drug and Strength
73362000801SKYTROFA 7.6 MG CARTRIDGE027New Drug and Strength
73362000901SKYTROFA 9.1 MG CARTRIDGE027New Drug and Strength
00338005403SODIUM CHLORIDE 3% IV SOLUTION35303New Strength
81749000401TARPEYO DR 4 MG CAPSULE DR420New Drug
70752012905TRIAMCINOLONE 0.025% LOTION [Kenalog]52393New Manufacturer and Strength
68135008236VOXZOGO 0.4 MG VIAL033New Drug and Strength
68135011966VOXZOGO 0.56 MG VIAL033New Drug and Strength
68135018193VOXZOGO 1.2 MG VIAL033New Drug and Strength




Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting your Medicare plan
Star Ratings & plan quality
Annual Medicare plan changes
Enrollment topics
Late Enrollment Penalty (LEP)
Your Formulary (Drug List)
Monthly Formulary changes
Your Medicare plan coverage
Pharmacies & Providers
Changing Medicare plans
Special Enrollment Periods (SEPs)
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and high costs
Out-of-Pocket: TrOOP, RxMOOP, and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for higher incomes
Medicare Advantage plans (MAPD)
Medicare Supplements - Medigap
Medicare plan providers
General Medicare Part D (PDP)
General Medicare
Diabetes and diabetic coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.